Stay updated on Cardiol Therapeutics Press Releases

Sign up to get notified when there's something new on the Cardiol Therapeutics Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Cardiol Therapeutics Press Releases page

  1. Check
    2 days ago
    Change Detected
    Summary
    Stock tickers NASDAQ:CRDL and TSX:CRDL were added to the page header along with current share prices $2.58 and $1.86. A Subscribe button was added to the investor resources area.
    Difference
    1%
    Check dated 2026-08-23T03:24:21.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The Press Releases page no longer displays the stock tickers TSX:CRDL and NASDAQ:CRDL or the prices $1.99 and $1.42, removing quick-access stock data from that section. This modifies how investors access current financial information on the page.
    Difference
    0.9%
    Check dated 2026-08-16T01:29:09.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    Updated stock prices to $1.42 and $1.99 and added a new press release about Cardiol Therapeutics' participation in Canaccord Genuity's 46th Annual Growth Conference; older stock prices ($1.27, $1.76) and the press release Cardiol Therapeutics Announces Year-End 2025 Update on Operations were removed.
    Difference
    1%
    Check dated 2026-08-08T23:03:24.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The investor section now shows updated stock price figures ($1.27 and $1.76), replacing the previous values ($1.18 and $1.67). The newsletter signup form labels were updated to include First, Last, and a required Name field.
    Difference
    1%
    Check dated 2026-08-01T17:42:44.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The stock price widget on the investor page now shows 1.18 and 1.67, down from 1.21 and 1.69. This reflects a small decline in listed market values.
    Difference
    0.5%
    Check dated 2026-07-25T13:00:19.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    Added new stock prices $1.21 and $1.69 and a July 14, 2026 press release about Phase II Recurrent Pericarditis data; removed older stock prices $1.01 and $1.44 and the February 25, 2026 press release about presenting at the TD Cowen conference.
    Difference
    1%
    Check dated 2026-07-18T08:46:44.000Z thumbnail image

Stay in the know with updates to Cardiol Therapeutics Press Releases

Enter your email address, and we'll notify you when there's something new on the Cardiol Therapeutics Press Releases page.